Cholesterol is a type of fat that is essential for many processes in the body, such as repairing damaged cells and producing certain hormones. Normally, cholesterol enters cells from the bloodstream and is then moved to the parts of the cell that need it via a process known as ‘trafficking’.

When cholesterol trafficking goes wrong, abnormally large amounts of cholesterol and other fats accumulate within the cell. Over time, these fatty deposits become toxic to cells and eventually damage the affected tissues. Niemann-Pick type C disease (NPC) is a severe genetic disorder affecting cholesterol trafficking. It is characterized by cholesterol build-up in multiple tissues, including the brain, which ultimately causes degeneration and death of nerve cells.

Two proteins, NPC1 and NPC2, are involved in NPC disease. Both proteins normally help move cholesterol out of important trafficking compartments (known as the endosomal and lysosomal compartments) to other areas of the cell where it is needed. Patients with the disease can have mutations in either the gene for NPC1 or the gene for NPC2. This means that cells from NPC1 patients do not make enough functional NPC1 protein (but contain working NPC2), and vice versa.

Previous studies had shown that giving cells with NPC1 mutations large amounts of the small molecule lysobisphosphatidic acid (LBPA for short) could compensate for the loss of NPC1, and stop the toxic build-up of cholesterol. McCauliff, Langan, Li et al. therefore wanted to explore exactly how LBPA was doing this. They had shown that LBPA dramatically increased the ability of purified NPC2 protein to transport cholesterol, and wondered if the effect of LBPA in the cells without NPC1 depended on NPC2. They predicted that boosting LBPA levels would not work in cells lacking NPC2.

Biochemical experiments using purified protein showed that LBPA and NPC2 did indeed interact directly with each other. Systematically changing different building blocks of NPC2 revealed that a single region of the protein is sensitive to LBPA, and when this region was altered, LBPA could no longer interact with NPC2. Since LBPA is naturally produced by cells, they then stimulated cells grown in the laboratory to generate more LBPA using its precursor phosphatidylglycerol. They used cells from patients with mutations in either NPC1 or NPC2 and demonstrated that LBPA’s ability to reverse the accumulation of cholesterol was dependent on its interaction with NPC2. Thus, increasing LBPA levels in cells from patients with NPC1 mutations was beneficial, but had no effect on cells from patients with NPC2 mutations.

These results shed new light not only on how cells transport cholesterol, but also on potential methods to combat disorders of cellular cholesterol trafficking. In the future, LBPA could be developed as a genetically tailored, patient-specific therapy for diseases like NPC.

Cholesterol is a small, hydrophobic molecule that is a vital building block of cell membranes and a precursor for steroid hormones, bile salts, vitamin D, and oxysterol ligands for transcription factors. Intracellular transport of cholesterol is a highly regulated but, as yet, incompletely understood process. Perturbations can lead to detrimental outcomes such as in the lysosomal storage disorder Niemann Pick Type C (NPC) disease, where LDL-derived cholesterol becomes trapped within the late endosomal/lysosomal (LE/LY) system. The sterol particularly enriches LE/LY inner membranes which develop during endosome maturation as a means of compartmentalizing its contents (Gruenberg, 2001; Gruenberg, 2003; Matsuo et al., 2004). The accumulation of cholesterol in NPC disease is associated with amassing of other lipids in the LE/LY, disruption of post-lysosomal cholesterol metabolism, and ultimately clinical manifestations including organomegaly and neurological deterioration. In 95% of NPC cases, mutations in the large LE/LY transmembrane protein, NPC1, prevent proper export of cholesterol from the LE/LY to other cellular compartments. The remaining 5% of cases are caused by mutations in the small, 132-amino acid, soluble LE/LY protein, NPC2 (Peake and Vance, 2010; Vanier, 2010).

Similarities in the cellular and clinical phenotypes resulting from either NPC1 or NPC2 deficiency led to the suggestion that these two proteins function cooperatively in normal LE/LY cholesterol trafficking (Kwon et al., 2009; Sleat et al., 2004); a proposed model shows cholesterol directly transferred from NPC2, in the LE/LY lumen, to NPC1, located in the limiting membrane of the compartment (Estiu et al., 2013; Wang et al., 2010). Recent tertiary structural analyses identifying a potential NPC2 interacting domain on the NPC1 protein support this mode of cholesterol egress from the LE/LY compartment (Zhao et al., 2016). It is further proposed that cholesterol transfer from NPC2 to the luminally localized N-terminal domain of NPC1 allows sterol passage through the glycocalyx found at the luminal surface of the LE/LY limiting membrane, via concerted effort from membrane glycoproteins (Li et al., 2016).

NPC2 binds cholesterol with a 1:1 stoichiometry (Xu et al., 2007). Ko et al. (2003) showed that cholesterol binding was necessary but not sufficient for its cholesterol efflux function, and we later demonstrated that cholesterol transport was the second critical component of NPC2 functionality (Cheruku et al., 2006; Xu et al., 2008). We further showed that cholesterol transfer by NPC2 occurs via protein-membrane interactions (Cheruku et al., 2006; Xu et al., 2008). Using model membranes, we demonstrated a remarkable, order of magnitude stimulation in wild type NPC2 cholesterol transfer rates by the incorporation of lysobisphosphatidic acid (LBPA), also known as bis-monoacylglycerol phosphate (Cheruku et al., 2006; Xu et al., 2008). LBPA is a structural isomer of phosphatidylglyerol with an atypical phospholipid stereoconfiguration. It is localized primarily to inner LE/LY membranes and is thought to be involved not only in the formation of these internal membranes and their architecture, but also in the sorting and efflux of LE/LY components, including cholesterol (Gruenberg, 2003; Hullin-Matsuda et al., 2007; Kobayashi et al., 1998; Kobayashi et al., 1999; Möbius et al., 2003). Incubation of BHK cells and macrophages with an anti-LBPA monoclonal antibody results in cholesterol accumulation in the LE/LY compartment, resembling the NPC phenotype (Delton-Vandenbroucke et al., 2007; Kobayashi et al., 1999).

Interestingly, Chevallier et al. (2008) showed that by enriching NPC1-deficient cells with exogenously added LBPA, the cholesterol accumulation was reversed ; the underlying molecular mechanism for LBPA stimulated LE/LY cholesterol egress remains unknown. Based on the dramatic effects of LBPA on NPC2-mediated cholesterol transfer, we hypothesized that the mechanism of LBPA action involves its specific functional interaction with NPC2, such that LBPA enrichment of cells deficient in NPC2 would not reverse cholesterol accumulation, in contrast to what had been found in NPC1-deficient cells.

In the present studies we demonstrate that, indeed, LBPA enrichment does not lead to the clearance of cholesterol in NPC2-deficient cells despite the presence of functional NPC1. We show for the first time that the mechanism involves an obligate direct interaction of NPC2 with LBPA, identify the LBPA-sensitive domain on the NPC2 surface, and establish the essential functional nature of NPC2-LBPA interactions in cholesterol egress from the LE/LY compartment. The results identify a novel, heretofore unknown step in LE/LY cholesterol egress which is dependent upon LBPA interaction with the hydrophobic knob of NPC2 protein. This in turn suggests that LBPA enrichment may be used to effect cholesterol egress in cells with defective NPC1 but functional WT NPC2, and NPC2 with disease-causing mutations outside the hydrophobic knob domain.

LBPA was proposed to be involved in intracellular cholesterol trafficking based on the sterol accumulation which accompanies incubation of cells with an anti-LBPA antibody (Kobayashi et al., 1999), however the mechanism of LBPA action has remained unknown. In this study we have, for the first time, shown that LBPA function in cholesterol trafficking is obligately dependent upon its interaction with the NPC2 protein within the endo-lysosomal system. At the molecular level, we show that this novel step in intracellular cholesterol trafficking involves direct interaction of LBPA with the hydrophobic knob domain on NPC2. This surface domain is located near the cholesterol binding pocket, thus its insertion into the bilayer would position the protein to efficiently exchange cholesterol with the membrane. Recent molecular dynamic simulations show that LBPA, but not other phospholipids, may position NPC2 in an orientation that could promote protein-membrane sterol exchange (Enkavi et al., 2017), potentially inducing a conformational change in the binding pocket of NPC2 such that the off-rate of cholesterol is markedly increased, allowing for rapid transfer of cholesterol between protein and LBPA-enriched membranes.

A decade ago, the Gruenberg laboratory reported that viral-mediated supplementation of NPC1-deficient cells with exogenous LBPA reversed cholesterol accumulation in the diseased cells (Chevallier et al., 2008). Here we show that LBPA enrichment is, conversely, completely ineffective in cells expressing NPC1 but lacking NPC2, underscoring the required functional interaction of LBPA with the NPC2 protein. In our efforts to establish the molecular basis of this interaction, we found that several NPC2 mutants that could not reverse cholesterol accumulation in unsupplemented NPC2-deficient cells, became effective if the cells were first enriched with LBPA. The NPC2 mutations which were ‘rescued’ by LBPA enrichment are all localized outside of the hydrophobic knob domain. By contrast, mutations within the hydrophobic knob were insensitive to LBPA enrichment apart from H56A, which may be on the limiting edge of this region. Thus, LBPA is able to normalize deficient transfer by mutant NPC2 as long as the mutation is outside of the hydrophobic knob. Interestingly, direct interaction between NPC2 and NPC1, residing in the limiting LE/LY membrane, has also been identified as involving the hydrophobic knob region on NPC2 (Li et al., 2016; Wang et al., 2010). This highlights further the critical nature of this domain in intracellular cholesterol trafficking, such that the NPC2 hydrophobic knob is involved in both LBPA-dependent binding of cholesterol by NPC2 at inner-LE/LY membranes, and the delivery of cholesterol by NPC2 to the NPC1 N-terminal domain. Primary amino acid sequence comparisons reveal a high degree of conservation within the NPC2 hydrophobic knob domain for all species with the exception of yeast; interestingly, yeast lacks the LBPA phospholipid, indirectly supporting a functional interaction between the mammalian NPC2 hydrophobic knob and LBPA. Thus, we propose that the hydrophobic knob on NPC2 interacts with LBPA in the inner LE/LY membranes, leading to cholesterol extraction, with NPC2 then subsequently involved in the ‘handoff’ of the sterol to NPC1 in the limiting membrane of these organelles (Deffieu and Pfeffer, 2011; Infante et al., 2008; Li et al., 2016; Wang et al., 2010).

In healthy cells, the enrichment of inner LE/LY membranes with LBPA and concurrent decline in cholesterol content may be reflective of the efficient role LBPA plays in normal LE/LY cholesterol efflux. If direct interactions between LBPA and NPC2 are integral to this mechanism of efflux, a rate determining step may be their frequency of interaction and, thus, be partially dependent upon the concentration of both phospholipid and protein in the LE/LY compartment. While the concentration of LE/LY LBPA has been shown to increase in parallel with cholesterol and other lipids in NPC disease (Davidson et al., 2009; Sleat et al., 2004; Vanier, 1983), as also found here, it is possible that LBPA levels nevertheless remain too low, as previously suggested (Chevallier et al., 2008), to provide support for NPC2-mediated transport of the elevated cholesterol load. Our results using PG supplementation to augment LBPA levels further indicate that LBPA may become limiting in NPC1 disease. Importantly, we show here that LBPA enrichment cannot reverse cholesterol accumulation caused by NPC2 deficiency unless the mutation is outside the hydrophobic knob domain in which case PG supplementation is effective, as it is in NPC1-deficient cells. Interestingly, Chen et al. observed a pronounced association of the NPC2 protein with inner LE/LY membranes in cells of Npc1^-/- mice (Balb/c Npc1^nih), relative to WT (Chen et al., 2005), suggesting that increased recruitment of NPC2 to inner LE/LY membranes in NPC1 disease, where LBPA concentration is high, may be a compensatory mechanism to alleviate sterol accumulation.

Beyond its obligate interaction with NPC2 within the LE/LY, it is not yet clear how increased LBPA leads to the efflux of LE/LY cholesterol in the absence of NPC1 protein, although in recent studies we have found that increased concentrations of cellular LBPA increase macroautophagy in NPC1 deficient cells (data not shown). It is well known that impaired autophagy is present in NPC disease (Liao et al., 2007; Lieberman et al., 2012; Seranova et al., 2017), and stabilization of this pathway has been shown to reduce cholesterol accumulation in NPC1 disease (Dai et al., 2017; Ordonez et al., 2012; Sarkar et al., 2013). LBPA also displays a variety of other unique functions within the endo/lysosomal system that could potentially promote cholesterol efflux. Studies have demonstrated, for instance, that its transient interaction with the ESCRT-associated protein, ALIX, is required for the proper formation of multivesicular structures within the LE/LY (Matsuo et al., 2004), where cholesterol is localized (Fivaz, 2002); it is also found, along with cholesterol, on exosomes derived from fusion of inner lamellae with the limiting LE/LY membrane (Matsuo et al., 2004). Furthermore, it has recently been proposed that LBPA may influence cholesterol homeostasis beyond the confines of late endosomes and lysosomes, having been shown to be necessary for lipid droplet formation via Wnt signaling within the endoplasmic reticulum, where cholesteryl esters are synthesized (Scott et al., 2015). Within the endo/lysosomal system, however, our results demonstrating that cellular enrichment of LBPA cannot reverse cholesterol accumulation in cells lacking functional NPC2 protein indicate that the cholesterol efflux mechanism utilized by LBPA is dependent upon its interaction with NPC2.

LBPA is reported to comprise only 1% of total cellular phospholipids, but about 15 mol% of total phospholipids in the LE/LY (Chevallier et al., 2000; Kobayashi et al., 1998; Kobayashi et al., 2002). There is no agreement regarding which isomeric form of LBPA is predominant in cells, as the fatty acids can be linked at the sn-2 or sn-3 positions of each glycerol in the S or R conformation, though the sn-2, sn-2’ positions are currently favored (Chevallier et al., 2000; Kobayashi et al., 1998; Kobayashi et al., 2002; Mason et al., 1972; Matsuo et al., 2004). The 2,2’-LBPA was shown to be quite effective at mobilizing cholesterol in NPC1 disease cells while the 3,3’- and semi-LBPA isoforms were unable to promote sterol efflux. No difference in efficacy between S,S, S,R, and R,R LBPA isomers were noted, however, suggesting that the conformation of LBPA has no bearing on its ability to reverse cholesterol accumulation in NPC1 deficient cells (Chevallier et al., 2008). In agreement with this observation, we previously showed that the S,S, S,R, and R,R configurations of LBPA had little to no effect on in vitro cholesterol transfer rates by NPC2 protein (Xu et al., 2008). Similarly, in the present studies we observed little variation in NPC2 binding to these different LBPA stereoisomers. Regardless, we chose to use the presumed precursor and structural isomer of LBPA, phosphatidylglycerol, to increase the cellular LBPA content in these studies, obviating any potential concern about the LBPA isoform as the cells presumably generate the physiologically accurate form. PG is thought to convert to LBPA along the endo/lysosomal system (Hullin-Matsuda et al., 2007; Poorthuis and Hostetler, 1978), and studies have demonstrated that exogenously administered PG can be converted to LBPA in vivo (Somerharju and Renkonen, 1980), although the anabolic pathway of this conversion remains unknown. The present demonstration that PG supplementation specifically increases the LBPA content of all cells tested supports the hypothesis that PG is a precursor to LBPA. Cellular conversion of PG to LBPA has also been demonstrated in mammalian alveolar macrophages (Waite et al., 1987), lymphoblasts (Hullin-Matsuda et al., 2007) and RAW macrophages (Bouvier et al., 2009).

In addition to variations in stereochemistry, the cellular fatty acyl chain components of LBPA have been found to vary (Bouvier et al., 2009), with oleic acid and docosahexaenoic acid (DHA) reported to be selectively incorporated (Besson et al., 2006; Luquain et al., 2001). Here we found acyl chain-dependent differences in NPC2-LBPA interactions, with reduced binding to the 14-carbon saturated dimyristoyl-LBPA species relative to the 18-carbon monounsaturated dioleoyl-LBPA species. In prior work we showed that cholesterol transfer from NPC2 to membranes containing dioleoyl-LBPA was >2 fold faster than transfer to vesicles with dimyristoyl-LBPA (Xu et al., 2008). Taken together, the results suggest that the acyl composition but not the steroconfiguration of LBPA may be important in normal LE/LY cholesterol efflux. Ongoing studies focused on identifying the specific acyl-chain species that are most effective at stimulating LE/LY cholesterol clearance in an NPC phenotype, for instance, should inform both our understanding of intracellular cholesterol transport and the development of therapies for lysosomal storage disorders.

Based on the present results, we propose that the NPC2 hydrophobic knob domain inserts into LBPA enriched inner LE/LY membranes, interacting directly with the phospholipid. Given the ability of NPC2 to promote membrane-membrane interactions (Abdul-Hammed et al., 2010; McCauliff et al., 2011; McCauliff et al., 2015), we speculate that this interaction between LBPA and NPC2 is involved in the formation of membrane contact sites which could potentially exist between closely apposed inner LE/LY membranes and facilitate rapid transfer of sterol. Membrane contact sites have been shown to be important in intermembrane lipid transfer (Helle et al., 2013; Holthuis and Levine, 2005; Prinz, 2014), although none have yet been specifically described within the multivesicular LE/LY. Our results show that NPC2 promotes membrane-membrane interaction, and further indicate the ability of NPC2 to bind to LBPA; this interaction may represent one membrane contact point on inner LE/LY membranes. Our previous kinetic studies suggested that NPC2 interacts with other membrane phospholipids as well, and preliminary molecular dynamics simulations indicate that unlike LBPA, where NPC2 interacts at the hydrophobic knob, these interactions occur at NPC2 surface sites other than the knob domain (data not shown); such interactions could represent a second contact point within the inner LE/LY membranes. Interestingly, it has now been demonstrated that NPC2 also binds directly to NPC1 which resides in the limiting LE/LY membrane, and possibly also with LAMP proteins in these same membranes (Li et al., 2016). These could also be potential tether points for the NPC2 and would effectively bring inner LE/LY cholesterol-laden membranes in closer proximity to the limiting LE/LY membrane, which cholesterol must ultimately cross to exit the compartment.

The key finding of the present studies is that the primary mechanism by which LBPA stimulates LE/LY cholesterol efflux is critically dependent upon its interaction with functional NPC2. LBPA first appears on the internal vesicles and membranes of cholesterol rich multivesicular bodies characteristic of late endosomes (Gruenberg, 2003; Möbius et al., 2003) and increases in concentration through the pathway to cholesterol depleted lysosomes (Möbius et al., 2003). This localization overlaps with NPC2, targeted to late endosomes/lysosomes via the mannose-6-phosphate receptor (Naureckiene et al., 2000). While NPC1 is also targeted to late endosomes (Garver et al., 2000; Higgins et al., 1999; Neufeld et al., 1999), Blanchette-Mackie and colleagues observed that most NPC1 localizes to a specific set of LAMP2 positive, mannose 6-phosphate receptor negative vesicles that are distinct from cholesterol enriched LAMP2 positive lysosomes, where LBPA and NPC2 reside, suggesting that transient interactions between NPC1 positive organelles and cholesterol rich lysosomes occur to effect normal cholesterol egress via NPC2-NPC1 interaction (Neufeld et al., 1999). While several groups have reported NPC1-independent egress of cholesterol from the LE/LY (Boadu et al., 2012; Goldman and Krise, 2010; Kennedy et al., 2012), it is not clear whether these function in the normal situation, or whether they are manifested secondary to NPC1 dysfunction.

Under normal conditions it is likely that the critical functional interaction between NPC2 and LBPA, demonstrated in the present studies, is followed by an interaction between NPC2 and NPC1 at the limiting lysosomal membrane, allowing for cholesterol to egress from the endolysosomal system. However, our studies have also implied that in the presence of intact NPC2, bypassing dysfunctional NPC1 may be achieved via PG-mediated or direct LBPA enrichment. LBPA enrichment may also be effective in NPC2 cases where the mutation is in a residue outside of the hydrophobic knob. For example, a human mutation in D72 has been reported to be disease causing (Biesecker et al., 2009), and we found here that PG supplementation/LBPA enrichment allowed NPC2 deficient cells to be effectively cleared by the D72A protein; supplementation with D72A-NPC2 was entirely ineffective prior to LBPA enrichment. In a recent high-throughput screen for drugs that raise LBPA levels, (Moreau et al., 2019) showed that a compound which increased LBPA levels cleared cholesterol from an NPC2 patient cell line; the mutated residue in this instance, C93, lies outside the hydrophobic knob. Thus, the in vitro evidence strongly suggests that LBPA enrichment can affectively ameliorate cellular cholesterol accumulation in the majority of NPC disease cases, including potentially all NPC1 mutations as well as NPC2 mutations outside the hydrophobic knob.

Currently there is no cure for NPC disease. Pharmacological options are limited, and palliative care remains the standard for treatment of the disease, focusing on increasing the length and quality of life for affected patients. Based on the existing in vitro evidence, we propose that cellular LBPA enrichment is worth exploring as a possible therapy. Aerosolized phospholipids such as dipalmitoyl phosphatidylcholine are widely used to enhance pulmonary drug delivery (Duret et al., 2014), and can be adequately nebulized without losing compositional integrity (Schreier et al., 1994). PG itself, administered intranasally, has been used as a therapy by the Voelker group to effectively inhibit respiratory syncytial virus infection (Numata et al., 2010; Numata et al., 2013) and influenza A virus (Numata et al., 2012). Moreover, lipid based colloidal carriers are able to cross the blood brain barrier (BBB) when administered intranasally (Ganesan et al., 2018; Mittal et al., 2014; Patel and Patel, 2017; Tapeinos et al., 2017) and have recently been shown to be efficient drug delivery vehicles in the treatment of intrinsic brain tumors (van Woensel et al., 2013) and neurodegenerative diseases including Alzheimer’s (Agrawal et al., 2018; Tapeinos et al., 2017) and Parkinson’s (Tapeinos et al., 2017; Yang et al., 2016). Given the historical difficulties in treating the neurological effects of NPC disease, the development of a minimally invasive, effective treatment with intrinsic ability to cross the BBB is of interest.

All data generated or analysed during this study are included in the manuscript and supporting files.

1. 1. Lomize MA
   2. Lomize AL
   3. Pogozheva ID
   4. Mosberg HI

   (2006) Orientation of Proteins in Membranes (OPM) Database

   1nep, Epididymal secretory protein E1.

   https://opm.phar.umich.edu/proteins/271
2. 1. National Library of Medicine (US)
   2. National Center for Biotechnology Information

   (1988) NCBI Protein Database

   ID NP_006423.1. NPC intracellular cholesterol transporter 2 isoform 2 precursor [Homo sapiens].

   https://www.ncbi.nlm.nih.gov/protein/NP_006423.1
3. 1. National Library of Medicine (US)
   2. National Center for Biotechnology Information

   (1988) NCBI Protein Database

   ID NP_075898.1. NPC intracellular cholesterol transporter 2 precursor [Mus musculus].

   https://www.ncbi.nlm.nih.gov/protein/NP_075898.1
4. 1. National Library of Medicine (US)
   2. National Center for Biotechnology Information

   (1988) NCBI Protein Database

   ID NP_776343.1. NPC intracellular cholesterol transporter 2 precursor [Bos taurus].

   https://www.ncbi.nlm.nih.gov/protein/NP_776343.1
5. 1. National Library of Medicine (US)
   2. National Center for Biotechnology Information

   (1988) NCBI Protein Database

   ID XP_003987882.1. epididymal secretory protein E1 [Felis catus].

   https://www.ncbi.nlm.nih.gov/protein/XP_003987882.1
6. 1. National Library of Medicine (US)
   2. National Center for Biotechnology Information

   (1988) NCBI Protein Database

   ID NP_001009075.1. NPC intracellular cholesterol transporter 2 precursor [Pan troglodytes].

   https://www.ncbi.nlm.nih.gov/protein/NP_001009075.1
7. 1. National Library of Medicine (US)
   2. National Center for Biotechnology Information

   (1988) NCBI Protein Database

   ID KZV12184.1. NPC2 [Saccharomyces cerevisiae].

   https://www.ncbi.nlm.nih.gov/protein/KZV12184.1

1. 1. Abdul-Hammed M
   2. Breiden B
   3. Adebayo MA
   4. Babalola JO
   5. Schwarzmann G
   6. Sandhoff K

   (2010) Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion

   Journal of Lipid Research 51:1747–1760.

   https://doi.org/10.1194/jlr.M003822

   • PubMed
   • Google Scholar
2. 1. Agrawal M
   2. Saraf S
   3. Saraf S
   4. Antimisiaris SG
   5. Chougule MB
   6. Shoyele SA
   7. Alexander A

   (2018) Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs

   Journal of Controlled Release 281:139–177.

   https://doi.org/10.1016/j.jconrel.2018.05.011

   • PubMed
   • Google Scholar
3. 1. Akgoc Z
   2. Sena-Esteves M
   3. Martin DR
   4. Han X
   5. d'Azzo A
   6. Seyfried TN

   (2015) Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses

   Journal of Lipid Research 56:1006–1013.

   https://doi.org/10.1194/jlr.M057851

   • PubMed
   • Google Scholar
4. 1. Berzina Z
   2. Solanko LM
   3. Mehadi AS
   4. Jensen MLV
   5. Lund FW
   6. Modzel M
   7. Szomek M
   8. Solanko KA
   9. Dupont A
   10. Nielsen GK
   11. Heegaard CW
   12. Ejsing CS
   13. Wüstner D

   (2018) Niemann-Pick C2 protein regulates sterol transport between plasma membrane and late endosomes in human fibroblasts

   Chemistry and Physics of Lipids 213:48–61.

   https://doi.org/10.1016/j.chemphyslip.2018.03.006

   • PubMed
   • Google Scholar
5. 1. Besson N
   2. Hullin-Matsuda F
   3. Makino A
   4. Murate M
   5. Lagarde M
   6. Pageaux JF
   7. Kobayashi T
   8. Delton-Vandenbroucke I

   (2006) Selective incorporation of docosahexaenoic acid into lysobisphosphatidic acid in cultured THP-1 macrophages

   Lipids 41:189–196.

   https://doi.org/10.1007/s11745-006-5087-5

   • PubMed
   • Google Scholar
6. 1. Biesecker LG
   2. Mullikin JC
   3. Facio FM
   4. Turner C
   5. Cherukuri PF
   6. Blakesley RW
   7. Bouffard GG
   8. Chines PS
   9. Cruz P
   10. Hansen NF
   11. Teer JK
   12. Maskeri B
   13. Young AC
   14. Manolio TA
   15. Wilson AF
   16. Finkel T
   17. Hwang P
   18. Arai A
   19. Remaley AT
   20. Sachdev V
   21. Shamburek R
   22. Cannon RO
   23. Green ED
   24. NISC Comparative Sequencing Program

   (2009) The ClinSeq project: piloting large-scale genome sequencing for research in genomic medicine

   Genome Research 19:1665–1674.

   https://doi.org/10.1101/gr.092841.109

   • PubMed
   • Google Scholar
7. 1. Bligh EG
   2. Dyer WJ

   (1959) A rapid method of total lipid extraction and purification

   Canadian Journal of Biochemistry and Physiology 37:911–917.

   https://doi.org/10.1139/y59-099

   • PubMed
   • Google Scholar
8. 1. Boadu E
   2. Nelson RC
   3. Francis GA

   (2012) ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann–Pick C2 but not Niemann–Pick C1 protein

   Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1821:396–404.

   https://doi.org/10.1016/j.bbalip.2011.11.013

   • Google Scholar
9. 1. Bouvier J
   2. Zemski Berry KA
   3. Hullin-Matsuda F
   4. Makino A
   5. Michaud S
   6. Geloën A
   7. Murphy RC
   8. Kobayashi T
   9. Lagarde M
   10. Delton-Vandenbroucke I

   (2009) Selective decrease of bis(monoacylglycero)phosphate content in macrophages by high supplementation with docosahexaenoic acid

   Journal of Lipid Research 50:243–255.

   https://doi.org/10.1194/jlr.M800300-JLR200

   • PubMed
   • Google Scholar
10. 1. Bradford MM

    (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

    Analytical Biochemistry 72:248–254.

    https://doi.org/10.1016/0003-2697(76)90527-3

    • PubMed
    • Google Scholar
11. 1. Chen FW
    2. Gordon RE
    3. Ioannou YA

    (2005) NPC1 late endosomes contain elevated levels of non-esterified ('free') fatty acids and an abnormally glycosylated form of the NPC2 protein

    Biochemical Journal 390:549–561.

    https://doi.org/10.1042/BJ20050236

    • PubMed
    • Google Scholar
12. 1. Cheruku SR
    2. Xu Z
    3. Dutia R
    4. Lobel P
    5. Storch J

    (2006) Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport

    Journal of Biological Chemistry 281:31594–31604.

    https://doi.org/10.1074/jbc.M602765200

    • PubMed
    • Google Scholar
13. 1. Chevallier J
    2. Sakai N
    3. Robert F
    4. Kobayashi T
    5. Gruenberg J
    6. Matile S

    (2000) Rapid access to synthetic lysobisphosphatidic acids using P(III) chemistry

    Organic Letters 2:1859–1861.

    https://doi.org/10.1021/ol0059246

    • PubMed
    • Google Scholar
14. 1. Chevallier J
    2. Chamoun Z
    3. Jiang G
    4. Prestwich G
    5. Sakai N
    6. Matile S
    7. Parton RG
    8. Gruenberg J

    (2008) Lysobisphosphatidic acid controls endosomal cholesterol levels

    Journal of Biological Chemistry 283:27871–27880.

    https://doi.org/10.1074/jbc.M801463200

    • PubMed
    • Google Scholar
15. 1. Dai S
    2. Dulcey AE
    3. Hu X
    4. Wassif CA
    5. Porter FD
    6. Austin CP
    7. Ory DS
    8. Marugan J
    9. Zheng W

    (2017) Methyl-β-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK

    Autophagy 13:1435–1451.

    https://doi.org/10.1080/15548627.2017.1329081

    • PubMed
    • Google Scholar
16. 1. Das A
    2. Goldstein JL
    3. Anderson DD
    4. Brown MS
    5. Radhakrishnan A

    (2013) Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells

    PNAS 110:10580–10585.

    https://doi.org/10.1073/pnas.1309273110

    • PubMed
    • Google Scholar
17. 1. Davidson CD
    2. Ali NF
    3. Micsenyi MC
    4. Stephney G
    5. Renault S
    6. Dobrenis K
    7. Ory DS
    8. Vanier MT
    9. Walkley SU

    (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression

    PLOS ONE 4:e6951.

    https://doi.org/10.1371/journal.pone.0006951

    • PubMed
    • Google Scholar
18. 1. Deffieu MS
    2. Pfeffer SR

    (2011) Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding

    PNAS 108:18932–18936.

    https://doi.org/10.1073/pnas.1110439108

    • PubMed
    • Google Scholar
19. 1. Degorce F
    2. Card A
    3. Soh S
    4. Trinquet E
    5. Knapik GP
    6. Xie B

    (2009) HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications

    Current Chemical Genomics 3:22–32.

    https://doi.org/10.2174/1875397300903010022

    • PubMed
    • Google Scholar
20. 1. Delton-Vandenbroucke I
    2. Bouvier J
    3. Makino A
    4. Besson N
    5. Pageaux JF
    6. Lagarde M
    7. Kobayashi T

    (2007) Anti-bis(monoacylglycero)phosphate antibody accumulates acetylated LDL-derived cholesterol in cultured macrophages

    Journal of Lipid Research 48:543–552.

    https://doi.org/10.1194/jlr.M600266-JLR200

    • PubMed
    • Google Scholar
21. 1. Dowler S
    2. Kular G
    3. Alessi DR

    (2002) Protein lipid overlay assay

    Science's STKE : Signal Transduction Knowledge Environment 2002:pl6.

    https://doi.org/10.1126/stke.2002.129.pl6

    • PubMed
    • Google Scholar
22. 1. Duret C
    2. Merlos R
    3. Wauthoz N
    4. Sebti T
    5. Vanderbist F
    6. Amighi K

    (2014) Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention

    European Journal of Pharmaceutics and Biopharmaceutics 86:46–54.

    https://doi.org/10.1016/j.ejpb.2013.03.005

    • PubMed
    • Google Scholar
23. 1. Enkavi G
    2. Mikkolainen H
    3. Güngör B
    4. Ikonen E
    5. Vattulainen I

    (2017) Concerted regulation of npc2 binding to endosomal/lysosomal membranes by bis(monoacylglycero)phosphate and sphingomyelin

    PLOS Computational Biology 13:e1005831.

    https://doi.org/10.1371/journal.pcbi.1005831

    • PubMed
    • Google Scholar
24. 1. Estiu G
    2. Khatri N
    3. Wiest O

    (2013) Computational studies of the cholesterol transport between NPC2 and the N-terminal domain of NPC1 (NPC1(NTD))

    Biochemistry 52:6879–6891.

    https://doi.org/10.1021/bi4005478

    • PubMed
    • Google Scholar
25. 1. Fivaz M

    (2002) Differential sorting and fate of endocytosed GPI-anchored proteins

    The EMBO Journal 21:3989–4000.

    https://doi.org/10.1093/emboj/cdf398

    • Google Scholar
26. 1. Fleury L
    2. Faux C
    3. Santos C
    4. Ballereau S
    5. Génisson Y
    6. Ausseil F

    (2015) Development of a CERT START Domain-Ceramide HTRF binding assay and application to pharmacological studies and screening

    Journal of Biomolecular Screening 20:779–787.

    https://doi.org/10.1177/1087057115573402

    • PubMed
    • Google Scholar
27. 1. Friedland N
    2. Liou HL
    3. Lobel P
    4. Stock AM

    (2003) Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease

    PNAS 100:2512–2517.

    https://doi.org/10.1073/pnas.0437840100

    • PubMed
    • Google Scholar
28. 1. Ganesan P
    2. Ramalingam P
    3. Karthivashan G
    4. Ko YT
    5. Choi DK

    (2018) Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases

    International Journal of Nanomedicine 13:1569–1583.

    https://doi.org/10.2147/IJN.S155593

    • PubMed
    • Google Scholar
29. 1. Garver WS
    2. Heidenreich RA
    3. Erickson RP
    4. Thomas MA
    5. Wilson JM

    (2000)

    Localization of the murine niemann-pick C1 protein to two distinct intracellular compartments

    Journal of Lipid Research 41:673–687.

    • PubMed
    • Google Scholar
30. 1. Gasteiger E
    2. Hoogland C
    3. Gattiker A
    4. Duvaud S
    5. Wilkins M
    6. Appel R
    7. Bairoch A

    (2005)

    Protein Identification and Analysis Tools on the ExPASy Server

    The proteomics protocols handbook, Protein Identification and Analysis Tools on the ExPASy Server, Humana Press.

    • Google Scholar
31. 1. Goldman SD
    2. Krise JP

    (2010) Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo

    Journal of Biological Chemistry 285:4983–4994.

    https://doi.org/10.1074/jbc.M109.037622

    • PubMed
    • Google Scholar
32. 1. Gomori G

    (1942)

    A modification of the colorimetric phosphorus determination for use with the photoelectric colorimeter

    Journal of Laboratory and Clinical Medicine 27:955–960.

    • Google Scholar
33. 1. Gruenberg J

    (2001) The endocytic pathway: a mosaic of domains

    Nature Reviews Molecular Cell Biology 2:721–730.

    https://doi.org/10.1038/35096054

    • PubMed
    • Google Scholar
34. 1. Gruenberg J

    (2003) Lipids in Endocytic membrane transport and sorting

    Current Opinion in Cell Biology 15:382–388.

    https://doi.org/10.1016/S0955-0674(03)00078-4

    • PubMed
    • Google Scholar
35. 1. Helle SCJ
    2. Kanfer G
    3. Kolar K
    4. Lang A
    5. Michel AH
    6. Kornmann B

    (2013) Organization and function of membrane contact sites

    Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research 1833:2526–2541.

    https://doi.org/10.1016/j.bbamcr.2013.01.028

    • Google Scholar
36. 1. Higgins ME
    2. Davies JP
    3. Chen FW
    4. Ioannou YA

    (1999) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network

    Molecular Genetics and Metabolism 68:1–13.

    https://doi.org/10.1006/mgme.1999.2882

    • PubMed
    • Google Scholar
37. 1. Holthuis JCM
    2. Levine TP

    (2005) Lipid traffic: floppy drives and a superhighway

    Nature Reviews Molecular Cell Biology 6:209–220.

    https://doi.org/10.1038/nrm1591

    • Google Scholar
38. 1. Hullin-Matsuda F
    2. Kawasaki K
    3. Delton-Vandenbroucke I
    4. Xu Y
    5. Nishijima M
    6. Lagarde M
    7. Schlame M
    8. Kobayashi T

    (2007) De novo biosynthesis of the late endosome lipid, bis(monoacylglycero)phosphate

    Journal of Lipid Research 48:1997–2008.

    https://doi.org/10.1194/jlr.M700154-JLR200

    • PubMed
    • Google Scholar
39. 1. Infante RE
    2. Wang ML
    3. Radhakrishnan A
    4. Kwon HJ
    5. Brown MS
    6. Goldstein JL

    (2008) NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes

    PNAS 105:15287–15292.

    https://doi.org/10.1073/pnas.0807328105

    • PubMed
    • Google Scholar
40. 1. Kennedy BE
    2. Charman M
    3. Karten B

    (2012) Niemann-Pick type C2 protein contributes to the transport of endosomal cholesterol to mitochondria without interacting with NPC1

    Journal of Lipid Research 53:2632–2642.

    https://doi.org/10.1194/jlr.M029942

    • PubMed
    • Google Scholar
41. 1. Ko DC
    2. Binkley J
    3. Sidow A
    4. Scott MP

    (2003) The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels

    PNAS 100:2518–2525.

    https://doi.org/10.1073/pnas.0530027100

    • PubMed
    • Google Scholar
42. 1. Kobayashi T
    2. Stang E
    3. Fang KS
    4. de Moerloose P
    5. Parton RG
    6. Gruenberg J

    (1998) A lipid associated with the antiphospholipid syndrome regulates endosome structure and function

    Nature 392:193–197.

    https://doi.org/10.1038/32440

    • PubMed
    • Google Scholar
43. 1. Kobayashi T
    2. Beuchat MH
    3. Lindsay M
    4. Frias S
    5. Palmiter RD
    6. Sakuraba H
    7. Parton RG
    8. Gruenberg J

    (1999) Late endosomal membranes rich in Lysobisphosphatidic acid regulate cholesterol transport

    Nature Cell Biology 1:113–118.

    https://doi.org/10.1038/10084

    • PubMed
    • Google Scholar
44. 1. Kobayashi T
    2. Beuchat MH
    3. Chevallier J
    4. Makino A
    5. Mayran N
    6. Escola JM
    7. Lebrand C
    8. Cosson P
    9. Kobayashi T
    10. Gruenberg J

    (2002) Separation and characterization of late endosomal membrane domains

    Journal of Biological Chemistry 277:32157–32164.

    https://doi.org/10.1074/jbc.M202838200

    • PubMed
    • Google Scholar
45. 1. Kwon HJ
    2. Abi-Mosleh L
    3. Wang ML
    4. Deisenhofer J
    5. Goldstein JL
    6. Brown MS
    7. Infante RE

    (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol

    Cell 137:1213–1224.

    https://doi.org/10.1016/j.cell.2009.03.049

    • PubMed
    • Google Scholar
46. 1. Kyte J
    2. Doolittle RF

    (1982) A simple method for displaying the hydropathic character of a protein

    Journal of Molecular Biology 157:105–132.

    https://doi.org/10.1016/0022-2836(82)90515-0

    • PubMed
    • Google Scholar
47. 1. Li X
    2. Saha P
    3. Li J
    4. Blobel G
    5. Pfeffer SR

    (2016) Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2

    PNAS 113:10079–10084.

    https://doi.org/10.1073/pnas.1611956113

    • PubMed
    • Google Scholar
48. 1. Li J
    2. Lee PL
    3. Pfeffer SR

    (2017) Quantitative measurement of cholesterol in cell populations using flow cytometry and fluorescent perfringolysin O

    Methods in Molecular Biology 1583:85–95.

    https://doi.org/10.1007/978-1-4939-6875-6_8

    • PubMed
    • Google Scholar
49. 1. Liao G
    2. Yao Y
    3. Liu J
    4. Yu Z
    5. Cheung S
    6. Xie A
    7. Liang X
    8. Bi X

    (2007) Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain

    The American Journal of Pathology 171:962–975.

    https://doi.org/10.2353/ajpath.2007.070052

    • PubMed
    • Google Scholar
50. 1. Lieberman AP
    2. Puertollano R
    3. Raben N
    4. Slaugenhaupt S
    5. Walkley SU
    6. Ballabio A

    (2012) Autophagy in lysosomal storage disorders

    Autophagy 8:719–730.

    https://doi.org/10.4161/auto.19469

    • Google Scholar
51. 1. Liou HL
    2. Dixit SS
    3. Xu S
    4. Tint GS
    5. Stock AM
    6. Lobel P

    (2006) NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols

    Journal of Biological Chemistry 281:36710–36723.

    https://doi.org/10.1074/jbc.M608743200

    • PubMed
    • Google Scholar
52. 1. Lomize MA
    2. Pogozheva ID
    3. Joo H
    4. Mosberg HI
    5. Lomize AL

    (2012) OPM database and PPM web server: resources for positioning of proteins in membranes

    Nucleic Acids Research 40:D370–D376.

    https://doi.org/10.1093/nar/gkr703

    • PubMed
    • Google Scholar
53. 1. Lu F
    2. Liang Q
    3. Abi-Mosleh L
    4. Das A
    5. De Brabander JK
    6. Goldstein JL
    7. Brown MS

    (2015) Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and ebola infection

    eLife 4:e12177.

    https://doi.org/10.7554/eLife.12177

    • PubMed
    • Google Scholar
54. 1. Luquain C
    2. Laugier C
    3. Lagarde M
    4. Pageaux JF

    (2001) High-performance liquid chromatography determination of bis(monoacylglycerol) phosphate and other lysophospholipids

    Analytical Biochemistry 296:41–48.

    https://doi.org/10.1006/abio.2001.5158

    • PubMed
    • Google Scholar
55. 1. Luquain-Costaz C
    2. Lefai E
    3. Arnal-Levron M
    4. Markina D
    5. Sakaï S
    6. Euthine V
    7. Makino A
    8. Guichardant M
    9. Yamashita S
    10. Kobayashi T
    11. Lagarde M
    12. Moulin P
    13. Delton-Vandenbroucke I

    (2013) Bis(monoacylglycero)phosphate accumulation in macrophages induces intracellular cholesterol redistribution, attenuates liver-X receptor/ATP-Binding cassette transporter A1/ATP-binding cassette transporter G1 pathway, and impairs cholesterol efflux

    Arteriosclerosis, Thrombosis, and Vascular Biology 33:1803–1811.

    https://doi.org/10.1161/ATVBAHA.113.301857

    • PubMed
    • Google Scholar
56. 1. Mason RJ
    2. Stossel TP
    3. Vaughan M

    (1972) Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles

    Journal of Clinical Investigation 51:2399–2407.

    https://doi.org/10.1172/JCI107052

    • PubMed
    • Google Scholar
57. 1. Matsuo H
    2. Chevallier J
    3. Mayran N
    4. Le Blanc
    5. Ferguson C
    6. Fauré J
    7. Blanc NS
    8. Matile S
    9. Dubochet J
    10. Sadoul R
    11. Parton RG
    12. Vilbois F
    13. Gruenberg J

    (2004) Role of LBPA and alix in Multivesicular liposome formation and endosome organization

    Science 303:531–534.

    https://doi.org/10.1126/science.1092425

    • PubMed
    • Google Scholar
58. 1. McCauliff LA
    2. Xu Z
    3. Storch J

    (2011) Sterol transfer between cyclodextrin and membranes: similar but not identical mechanism to NPC2-mediated cholesterol transfer

    Biochemistry 50:7341–7349.

    https://doi.org/10.1021/bi200574f

    • PubMed
    • Google Scholar
59. 1. McCauliff LA
    2. Xu Z
    3. Li R
    4. Kodukula S
    5. Ko DC
    6. Scott MP
    7. Kahn PC
    8. Storch J

    (2015) Multiple surface regions on the Niemann-Pick C2 protein facilitate intracellular cholesterol transport

    Journal of Biological Chemistry 290:27321–27331.

    https://doi.org/10.1074/jbc.M115.667469

    • PubMed
    • Google Scholar
60. 1. Mittal D
    2. Ali A
    3. Md S
    4. Baboota S
    5. Sahni JK
    6. Ali J

    (2014) Insights into direct nose to brain delivery: current status and future perspective

    Drug Delivery 21:75–86.

    https://doi.org/10.3109/10717544.2013.838713

    • PubMed
    • Google Scholar
61. 1. Möbius W
    2. van Donselaar E
    3. Ohno-Iwashita Y
    4. Shimada Y
    5. Heijnen HF
    6. Slot JW
    7. Geuze HJ

    (2003) Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway

    Traffic 4:222–231.

    https://doi.org/10.1034/j.1600-0854.2003.00072.x

    • PubMed
    • Google Scholar
62. 1. Moreau D
    2. Vacca F
    3. Vossio S
    4. Scott C
    5. Colaco A
    6. Paz Montoya J
    7. Ferguson C
    8. Damme M
    9. Moniatte M
    10. Parton RG
    11. Platt FM
    12. Gruenberg J

    (2019) Drug-induced increase in Lysobisphosphatidic acid reduces the cholesterol overload in Niemann-Pick type C cells and mice

    EMBO Reports 20:.

    https://doi.org/10.15252/embr.201847055

    • PubMed
    • Google Scholar
63. 1. Naureckiene S
    2. Sleat DE
    3. Lackland H
    4. Fensom A
    5. Vanier MT
    6. Wattiaux R
    7. Jadot M
    8. Lobel P

    (2000) Identification of HE1 as the second gene of Niemann-Pick C disease

    Science 290:2298–2301.

    https://doi.org/10.1126/science.290.5500.2298

    • PubMed
    • Google Scholar
64. 1. Neufeld EB
    2. Wastney M
    3. Patel S
    4. Suresh S
    5. Cooney AM
    6. Dwyer NK
    7. Roff CF
    8. Ohno K
    9. Morris JA
    10. Carstea ED
    11. Incardona JP
    12. Strauss JF
    13. Vanier MT
    14. Patterson MC
    15. Brady RO
    16. Pentchev PG
    17. Blanchette-Mackie EJ

    (1999) The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo

    Journal of Biological Chemistry 274:9627–9635.

    https://doi.org/10.1074/jbc.274.14.9627

    • PubMed
    • Google Scholar
65. 1. Numata M
    2. Chu HW
    3. Dakhama A
    4. Voelker DR

    (2010) Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

    PNAS 107:320–325.

    https://doi.org/10.1073/pnas.0909361107

    • PubMed
    • Google Scholar
66. 1. Numata M
    2. Kandasamy P
    3. Nagashima Y
    4. Posey J
    5. Hartshorn K
    6. Woodland D
    7. Voelker DR

    (2012) Phosphatidylglycerol suppresses influenza A virus infection

    American Journal of Respiratory Cell and Molecular Biology 46:479–487.

    https://doi.org/10.1165/rcmb.2011-0194OC

    • PubMed
    • Google Scholar
67. 1. Numata M
    2. Nagashima Y
    3. Moore ML
    4. Berry KZ
    5. Chan M
    6. Kandasamy P
    7. Peebles RS
    8. Murphy RC
    9. Voelker DR

    (2013) Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection

    Journal of Lipid Research 54:2133–2143.

    https://doi.org/10.1194/jlr.M037077

    • PubMed
    • Google Scholar
68. 1. Ordonez MP
    2. Roberts EA
    3. Kidwell CU
    4. Yuan SH
    5. Plaisted WC
    6. Goldstein LS

    (2012) Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann pick type C1

    Human Molecular Genetics 21:2651–2662.

    https://doi.org/10.1093/hmg/dds090

    • PubMed
    • Google Scholar
69. 1. Patel MM
    2. Patel BM

    (2017) Crossing the Blood-Brain barrier: recent advances in drug delivery to the brain

    CNS Drugs 31:109–133.

    https://doi.org/10.1007/s40263-016-0405-9

    • PubMed
    • Google Scholar
70. 1. Peake KB
    2. Vance JE

    (2010) Defective cholesterol trafficking in Niemann-Pick C-deficient cells

    FEBS Letters 584:2731–2739.

    https://doi.org/10.1016/j.febslet.2010.04.047

    • PubMed
    • Google Scholar
71. 1. Pearson WR

    (2013) Selecting the right similarity-scoring matrix

    Current Protocols in Bioinformatics 9:.

    https://doi.org/10.1002/0471250953.bi0305s43

    • Google Scholar
72. 1. Petruševska M
    2. Urleb U
    3. Peternel L

    (2013) Evaluation of the light scattering and the turbidity microtiter plate-based methods for the detection of the excipient-mediated drug precipitation inhibition

    European Journal of Pharmaceutics and Biopharmaceutics 85:1148–1156.

    https://doi.org/10.1016/j.ejpb.2013.08.015

    • PubMed
    • Google Scholar
73. 1. Poorthuis BJ
    2. Hostetler KY

    (1978)

    Conversion of diphosphatidylglycerol to bis(monoacylglyceryl)phosphate by lysosomes

    Journal of Lipid Research 19:309–315.

    • PubMed
    • Google Scholar
74. 1. Prinz WA

    (2014) Bridging the gap: membrane contact sites in signaling, metabolism, and organelle dynamics

    The Journal of Cell Biology 205:759–769.

    https://doi.org/10.1083/jcb.201401126

    • PubMed
    • Google Scholar
75. 1. Sarkar S
    2. Carroll B
    3. Buganim Y
    4. Maetzel D
    5. Ng AH
    6. Cassady JP
    7. Cohen MA
    8. Chakraborty S
    9. Wang H
    10. Spooner E
    11. Ploegh H
    12. Gsponer J
    13. Korolchuk VI
    14. Jaenisch R

    (2013) Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease

    Cell Reports 5:1302–1315.

    https://doi.org/10.1016/j.celrep.2013.10.042

    • PubMed
    • Google Scholar
76. 1. Schreier H
    2. Mobley WC
    3. Concessio N
    4. Hickey A
    5. Niven RW

    (1994)

    Formulation of in-vitro performance of liposome powder aerosols

    S.T.P. Pharma Sciences 4:38–44.

    • Google Scholar
77. 1. Schulz TA
    2. Choi MG
    3. Raychaudhuri S
    4. Mears JA
    5. Ghirlando R
    6. Hinshaw JE
    7. Prinz WA

    (2009) Lipid-regulated sterol transfer between closely apposed membranes by oxysterol-binding protein homologues

    The Journal of Cell Biology 187:889–903.

    https://doi.org/10.1083/jcb.200905007

    • PubMed
    • Google Scholar
78. 1. Scott CC
    2. Vossio S
    3. Vacca F
    4. Snijder B
    5. Larios J
    6. Schaad O
    7. Guex N
    8. Kuznetsov D
    9. Martin O
    10. Chambon M
    11. Turcatti G
    12. Pelkmans L
    13. Gruenberg J

    (2015) Wnt directs the endosomal flux of LDL-derived cholesterol and lipid droplet homeostasis

    EMBO Reports 16:741–752.

    https://doi.org/10.15252/embr.201540081

    • PubMed
    • Google Scholar
79. 1. Seranova E
    2. Connolly KJ
    3. Zatyka M
    4. Rosenstock TR
    5. Barrett T
    6. Tuxworth RI
    7. Sarkar S

    (2017) Dysregulation of autophagy as a common mechanism in lysosomal storage diseases

    Essays in Biochemistry 61:733–749.

    https://doi.org/10.1042/EBC20170055

    • PubMed
    • Google Scholar
80. 1. Sievers F
    2. Wilm A
    3. Dineen D
    4. Gibson TJ
    5. Karplus K
    6. Li W
    7. Lopez R
    8. McWilliam H
    9. Remmert M
    10. Söding J
    11. Thompson JD
    12. Higgins DG

    (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega

    Molecular Systems Biology 7:539.

    https://doi.org/10.1038/msb.2011.75

    • PubMed
    • Google Scholar
81. 1. Sleat DE
    2. Wiseman JA
    3. El-Banna M
    4. Price SM
    5. Verot L
    6. Shen MM
    7. Tint GS
    8. Vanier MT
    9. Walkley SU
    10. Lobel P

    (2004) Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport

    PNAS 101:5886–5891.

    https://doi.org/10.1073/pnas.0308456101

    • PubMed
    • Google Scholar
82. 1. Somerharju P
    2. Renkonen O

    (1980) Conversion of phosphatidylglycerol lipids to bis(monoacylglycero)phosphate in vivo

    Biochimica Et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 618:407–419.

    https://doi.org/10.1016/0005-2760(80)90259-3

    • PubMed
    • Google Scholar
83. 1. Storch J
    2. Bass NM

    (1990)

    Transfer of fluorescent fatty acids from liver and heart fatty acid-binding proteins to model membranes

    The Journal of Biological Chemistry 265:7827–7831.

    • PubMed
    • Google Scholar
84. 1. Storch J
    2. Kleinfeld AM

    (1986) Transfer of long-chain fluorescent free fatty acids between unilamellar vesicles

    Biochemistry 25:1717–1726.

    https://doi.org/10.1021/bi00355a041

    • PubMed
    • Google Scholar
85. 1. Tapeinos C
    2. Battaglini M
    3. Ciofani G

    (2017) Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases

    Journal of Controlled Release 264:306–332.

    https://doi.org/10.1016/j.jconrel.2017.08.033

    • PubMed
    • Google Scholar
86. 1. Thornburg T
    2. Miller C
    3. Thuren T
    4. King L
    5. Waite M

    (1991)

    Glycerol reorientation during the conversion of phosphatidylglycerol to bis(monoacylglycerol)phosphate in macrophage-like RAW 264.7 cells

    The Journal of Biological Chemistry 266:6834–6840.

    • PubMed
    • Google Scholar
87. 1. van Woensel M
    2. Wauthoz N
    3. Rosière R
    4. Amighi K
    5. Mathieu V
    6. Lefranc F
    7. van Gool SW
    8. de Vleeschouwer S

    (2013) Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?

    Cancers 5:1020–1048.

    https://doi.org/10.3390/cancers5031020

    • PubMed
    • Google Scholar
88. 1. Vanier MT

    (1983) Biochemical studies in Niemann-Pick disease. I. major sphingolipids of liver and spleen

    Biochimica Et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 750:178–184.

    https://doi.org/10.1016/0005-2760(83)90218-7

    • PubMed
    • Google Scholar
89. 1. Vanier MT

    (2010) Niemann-pick disease type C

    Orphanet Journal of Rare Diseases 5:16.

    https://doi.org/10.1186/1750-1172-5-16

    • PubMed
    • Google Scholar
90. 1. Waite M
    2. Roddick V
    3. Thornburg T
    4. King L
    5. Cochran F

    (1987) Conversion of phosphatidylglycerol to lyso(bis)phosphatidic acid by alveolar macrophages

    The FASEB Journal 1:318–325.

    https://doi.org/10.1096/fasebj.1.4.3653583

    • PubMed
    • Google Scholar
91. 1. Wang ML
    2. Motamed M
    3. Infante RE
    4. Abi-Mosleh L
    5. Kwon HJ
    6. Brown MS
    7. Goldstein JL

    (2010) Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes

    Cell Metabolism 12:166–173.

    https://doi.org/10.1016/j.cmet.2010.05.016

    • PubMed
    • Google Scholar
92. 1. Wootan MG
    2. Storch J

    (1994)

    Regulation of fluorescent fatty acid transfer from adipocyte and heart fatty acid binding proteins by acceptor membrane lipid composition and structure

    The Journal of Biological Chemistry 269:10517–10523.

    • PubMed
    • Google Scholar
93. 1. Xu S
    2. Benoff B
    3. Liou HL
    4. Lobel P
    5. Stock AM

    (2007) Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease

    Journal of Biological Chemistry 282:23525–23531.

    https://doi.org/10.1074/jbc.M703848200

    • PubMed
    • Google Scholar
94. 1. Xu Z
    2. Farver W
    3. Kodukula S
    4. Storch J

    (2008) Regulation of sterol transport between membranes and NPC2

    Biochemistry 47:11134–11143.

    https://doi.org/10.1021/bi801328u

    • PubMed
    • Google Scholar
95. 1. Yang PH
    2. Zhu JX
    3. Huang YD
    4. Zhang XY
    5. Lei P
    6. Bush AI
    7. Xiang Q
    8. Su ZJ
    9. Zhang QH

    (2016) Human basic fibroblast growth factor inhibits tau phosphorylation via the PI3K/Akt-GSK3β signaling pathway in a 6-Hydroxydopamine-Induced model of Parkinson's Disease

    Neuro-Degenerative Diseases 16:357–369.

    https://doi.org/10.1159/000445871

    • PubMed
    • Google Scholar
96. 1. Zhao Y
    2. Ren J
    3. Harlos K
    4. Stuart DI

    (2016) Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and ebola virus interactions

    FEBS Letters 590:605–612.

    https://doi.org/10.1002/1873-3468.12089

    • PubMed
    • Google Scholar

Author details

1. Leslie A McCauliff

   1. Department of Nutritional Sciences, Rutgers University, New Brunswick, United States
   2. Rutgers Center for Lipid Research, Rutgers University, New Brunswick, United States

   Contribution

   Conceptualization, Formal analysis, Funding acquisition, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing

   Contributed equally with

   Annette Langan and Ran Li

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-5744-2737

2. Annette Langan

   1. Department of Nutritional Sciences, Rutgers University, New Brunswick, United States
   2. Rutgers Center for Lipid Research, Rutgers University, New Brunswick, United States

   Contribution

   Formal analysis, Investigation, Visualization, Writing—original draft, Writing—review and editing

   Contributed equally with

   Leslie A McCauliff and Ran Li

   Competing interests

   No competing interests declared

3. Ran Li

   1. Department of Nutritional Sciences, Rutgers University, New Brunswick, United States
   2. Rutgers Center for Lipid Research, Rutgers University, New Brunswick, United States

   Contribution

   Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing

   Contributed equally with

   Leslie A McCauliff and Annette Langan

   Competing interests

   No competing interests declared

4. Olga Ilnytska

   1. Department of Nutritional Sciences, Rutgers University, New Brunswick, United States
   2. Rutgers Center for Lipid Research, Rutgers University, New Brunswick, United States

   Contribution

   Investigation, Visualization, Methodology, Writing—review and editing, Funding acquisition

   Competing interests

   No competing interests declared

5. Debosreeta Bose

   1. Department of Nutritional Sciences, Rutgers University, New Brunswick, United States
   2. Rutgers Center for Lipid Research, Rutgers University, New Brunswick, United States

   Contribution

   Investigation, Writing—review and editing

   Competing interests

   No competing interests declared

6. Miriam Waghalter

   Department of Nutritional Sciences, Rutgers University, New Brunswick, United States

   Contribution

   Investigation, Writing—review and editing

   Competing interests

   No competing interests declared

7. Kimberly Lai

   Department of Nutritional Sciences, Rutgers University, New Brunswick, United States

   Contribution

   Investigation, Writing—review and editing

   Competing interests

   No competing interests declared

8. Peter C Kahn

   Department of Biochemistry and Microbiology, Rutgers University, New Brunswick, United States

   Contribution

   Supervision, Writing—review and editing

   Competing interests

   No competing interests declared

9. Judith Storch

   1. Department of Nutritional Sciences, Rutgers University, New Brunswick, United States
   2. Rutgers Center for Lipid Research, Rutgers University, New Brunswick, United States

   Contribution

   Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Writing—original draft, Project administration, Writing—review and editing

   For correspondence

   storch@sebs.rutgers.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-5482-1777

• 4,017

  views

• 611

  downloads

• 54

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.